Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
---|
04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
04/01/2004 | US20040063665 Anticancer agents; high degree of discrimination toward malignant cells; reducing side effects; nontoxic; such as 3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one |
04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
04/01/2004 | DE10244282A1 Zubereitung mit antioxidanten Eigenschaften Composition having antioxidant properties |
04/01/2004 | DE10243906A1 9-Cyanosubstituierte Perylen-3,4-dicarbonsäuremonoimide 9-cyano-substituted perylene-3,4-dicarboxylic monoimides |
03/31/2004 | EP1401962A1 Method for increasing hydrophilicity of fluorescent label compounds |
03/31/2004 | EP1401823A1 Substituted benzopyran derivatives against arrhythmia |
03/31/2004 | EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
03/31/2004 | EP1114041B1 Process for the preparation of alpha-tocopherol acetate |
03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
03/31/2004 | CN1485325A Soybean extract with health-care function , its preparing process and use |
03/31/2004 | CN1485324A Method of membrane separation technique for producing seabuckthorn flavone |
03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
03/30/2004 | US6713622 Contacting a 4,7-dichlororhodamine dye comprising a linking group with a polynucleotide comprising a terminal functionality complementary to the linking group |
03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
03/30/2004 | US6713506 Inhibiting proteasomal chymotrypsin-like activity |
03/30/2004 | US6713228 Unsaturated ether containing polymer |
03/30/2004 | US6713146 Singly recordable compact disc (cd-r) |
03/30/2004 | CA2143441C Recovery of tocopherol and sterol |
03/30/2004 | CA2102812C Cholesterol-lowering tocopherol analogs |
03/25/2004 | WO2004025259A2 Site-specific labeling of affinity tags in fusion proteins |
03/25/2004 | WO2004024709A2 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
03/25/2004 | WO2004024093A2 Device and method for treating restenosis |
03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/25/2004 | WO2003060852A3 Catalytic osmium-assisted oxidative cleavage of olefins |
03/25/2004 | WO2003040134A9 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
03/25/2004 | US20040059145 Heterodiamondoids |
03/25/2004 | US20040059136 7-carboxy-flavone derivatives preparation method and therapeutic use |
03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
03/25/2004 | US20040059100 Metallating 2-hydroxyacetophenone compound using a lithium compound and subsequently reacted with a keto compound such as 3,4-dimethoxybenzoyl chloride; specific stoichiometry of Li compound |
03/25/2004 | US20040058987 Hypotensive agents; oxidation resistance, nitrogen scavenger; anticancer agents; antiischemic agents |
03/25/2004 | US20040058986 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
03/25/2004 | US20040058985 Coumarin analog compounds for safer anticoagulant treatment |
03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
03/25/2004 | US20040058931 Potassium channel inhibitors and method |
03/25/2004 | DE10243234A1 New tocopheryl esters of aminoacids or derivatives, useful in cosmetic or dermatological compositions, e.g. for protecting skin against osmotic and oxidative stress and/or treating inflammation |
03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/24/2004 | EP1400579A2 Composition with anti-oxidative properties |
03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
03/24/2004 | EP1315711B1 Method for producing dihydrocoumarin by hydrogenating coumarin |
03/24/2004 | EP0912543B1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate |
03/24/2004 | EP0904079B1 Antidiabetic agents |
03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
03/24/2004 | CN1142927C Chalcone coumarins |
03/23/2004 | US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds |
03/23/2004 | US6710188 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer |
03/23/2004 | CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
03/18/2004 | WO2004022703A2 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
03/18/2004 | WO2004022550A1 Compound for treatment of anxiety and methods of preparation and use thereof |
03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
03/18/2004 | WO2004007475A8 Flavonoid compounds as therapeutic antioxidants |
03/18/2004 | WO2003086563A3 Diabetes imaging probes |
03/18/2004 | US20040054195 Fluorescent dyes; photostability; labels, staining; analysis |
03/18/2004 | US20040053992 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
03/18/2004 | US20040053935 Anticancer agents |
03/18/2004 | US20040053934 Anticancer agents |
03/18/2004 | US20040053859 Preventive or therapeutic agent for cancer containing cyanidin compound as active ingredient |
03/18/2004 | US20040053858 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
03/18/2004 | US20040053383 Crystals of cytochrome P450 2C9, structures thereof and their use |
03/18/2004 | US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
03/18/2004 | CA2501924A1 Non-nucleoside reverse transcriptase inhibitors |
03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/17/2004 | EP1309572A4 Silent mark for oil product and detection method thereto |
03/17/2004 | CN1482126A Tea polyphenols extracting process |
03/17/2004 | CN1482125A Process for extracting lotus leaf flavone |
03/17/2004 | CN1482124A Preparation process for dragon's blood total flavonoids |
03/17/2004 | CN1142155C Use of ampelopsin for preparing antileukemie and anti-nasopharyngeal carcinoma medicines |
03/16/2004 | US6706898 Methods for separating a tocopherol from a tocopherol-containing mixture |
03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
03/16/2004 | US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
03/16/2004 | US6706292 Recovery of isoflavones from soy molasses |
03/11/2004 | WO2004020428A1 Process for producing aminobenzopyran compound |
03/11/2004 | WO2004020427A1 The process for preparation of total coumarins from cortex fraxini and their use in medicine |
03/11/2004 | WO2004019888A2 Process to prepare psorospermin |
03/11/2004 | WO2004019874A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
03/11/2004 | US20040049059 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
03/11/2004 | US20040049056 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both |
03/11/2004 | CA2513021A1 Process to prepare psorospermin |
03/11/2004 | CA2495192A1 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
03/10/2004 | EP1395615A1 Oxime ester photoinitiators having a combined structure |
03/10/2004 | EP1395596A2 Methods for preparation and use of psorospermin analogs |
03/10/2004 | EP1395539A1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood |
03/10/2004 | EP1214309B1 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid |
03/10/2004 | EP1124816B1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use |
03/10/2004 | EP1115717B1 3-(hydroxymethyl)chromen-4-ones and process for their preparation |
03/10/2004 | EP0957911B1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
03/10/2004 | CN1481392A Surface-active photoinitiators |
03/10/2004 | CN1480457A Method for extracting tea polyhenols and tea pigment |
03/10/2004 | CN1480456A Method for picking-up general flavone from hawthorn fruit by using microwave |
03/10/2004 | CN1480063A Method for producing base material of soybean isoflavone with sugariness taste |
03/10/2004 | CN1141304C Method for preparing viatmin E |
03/10/2004 | CN1141303C Process for enriching high-purity catechin |
03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
03/09/2004 | US6703514 4-thio coumarins |
03/09/2004 | US6703414 A stent comprised of a stent body coated with a compound of the following formula:with hetero compounds |
03/09/2004 | US6703384 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |